June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Longitudinal characterization of the Cln8mnd mouse model of CLN8 Batten Disease.
Author Affiliations & Notes
  • Marc Cerrada-Gimenez
    Experimentica Ltd., Kuopio, Finland
  • Giedrius Kalesnykas
    Experimentica Ltd., Kuopio, Finland
  • Kimmo Lehtimäki
    Charles River Discovery, Finland
  • Timmo Bragge
    Charles River Discovery, Finland
  • Jukka Puoliväli
    Charles River Discovery, Finland
  • Jussi Rytkönen
    Charles River Discovery, Finland
  • Pekka Poutiainen
    Kuopio University Hospital, Finland
  • Tyler Johnson
    Sanford Research, South Dakota, United States
  • Jacob Cain
    Sanford Research, South Dakota, United States
  • Samantha Davis
    Sanford Research, South Dakota, United States
  • Antti Nurmi
    Charles River Discovery, Finland
  • Jill Weimer
    Sanford Research, South Dakota, United States
  • Footnotes
    Commercial Relationships   Marc Cerrada-Gimenez, Experimentica Ltd. (E); Giedrius Kalesnykas, Experimentica Ltd. (I), Experimentica Ltd. (E), Experimentica Ltd. (S), Experimentica Ltd. (P), Experimentica Ltd. (R), Spouse - Experimentica Ltd. (S), Spouse - Experimentica Ltd. (I); Kimmo Lehtimäki, Charles River Discovery (E); Timmo Bragge, Charles River Discovery (E); Jukka Puoliväli, Charles River Discovery (E); Jussi Rytkönen, Charles River Discovery (E); Pekka Poutiainen, Charles River Discovery (C); Tyler Johnson, Sanford Research (E); Jacob Cain, Sanford Research (E); Samantha Davis, Sanford Research (E); Antti Nurmi, Charles River Discovery (I), Charles River Discovery (E); Jill Weimer, Sanford Research (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 2240. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Marc Cerrada-Gimenez, Giedrius Kalesnykas, Kimmo Lehtimäki, Timmo Bragge, Jukka Puoliväli, Jussi Rytkönen, Pekka Poutiainen, Tyler Johnson, Jacob Cain, Samantha Davis, Antti Nurmi, Jill Weimer; Longitudinal characterization of the Cln8mnd mouse model of CLN8 Batten Disease.. Invest. Ophthalmol. Vis. Sci. 2020;61(7):2240.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Northern epilepsy (CLN8) is the most common disease of the neuronal ceroid lipofuscinosis (NCL) family of neurodegenerative disorders, Batten disease. The NCL disorders affect the nervous system and produce alterations on visual, motor and cognitive skills. CLN8 is caused by mutations on the CLN8 gene coding for a transmembrane protein localized on the endoplasmic reticulum (https://ghr.nlm.nih.gov/condition/cln8-disease).

The naturally occurring motor neuron degeneration mouse (B6.KB2-Cln8mnd/MsrJ) presents a mutation in the Cln8 gene and it has been shown to be a model for CLN8 (Ranta and Lehesjoki 2000). This mouse strain is characterized by lipofuscin accumulation, motor dysfunction, retinal degeneration and mitochondrial degeneration (Messer et al. 1993; Cooper et al. 1999). We have characterized the Cln8mnd mouse model between two and eight months of age.

Methods : Kinematic gait analysis, T2 volumetry and DTI for white matter evaluation, 1H-MRS and FDG-PET metabolic profiling, and flash ERG data from both genders was collected at two, four, six and eight months of age.

Results : The male Cln8mnd mice showed significantly decreased whole brain volumes already by two months of age (98%, p < 0.01). Moreover, there is a clear appearance of demyelinated brain regions already at two months of age for both genders. The neurometabolic profile presented significant alterations starting at four months of age for the males (GPC, p = 0.005 and GSH, p = 0.034), and at six months of age for the females (Ala, p = 0.024 and TAU, p = 0.016). The functionality of the visual system appeared hindered by four months of age, with significant lower a-wave (3 cd.s/m2, 55%, p = 0.0001; 10 cd.s/m2, 53%, p < 0.0001) and B-wave amplitudes (3 cd.s/m2, 70%, p < 0.0001; 10 cd.s/m2, 69%, p < 0.0001). By eight months of age the mutant mice showed no response to fERG. Movement started to show significant impairment already by two months of age in both genders and worsen at six months (gait score, 81%, p < 0.01 and 0.001, respectively).

Conclusions : The Cln8mnd mouse strain showed significant differences in many of the parameters analyzed already at two months of age, brain volume, neurometabolic profile, visual function and movement. Upon aging the mutant mice phenotype worsened in all the parameters.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×